HomeSPRO • NASDAQ
Spero Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 5.87M | -36.61% |
Operating expense | 20.43M | 245.28% |
Net income | -13.87M | -9.45% |
Net profit margin | -236.06 | -72.67% |
Earnings per share | -0.25 | -3.02% |
EBITDA | -14.56M | -4.79% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 48.89M | -40.58% |
Total assets | 77.71M | -53.66% |
Total liabilities | 43.90M | -38.57% |
Total equity | 33.81M | — |
Shares outstanding | 55.91M | — |
Price to book | 1.09 | — |
Return on assets | -38.66% | — |
Return on capital | -82.52% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -13.87M | -9.45% |
Cash from operations | -4.00M | -167.40% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -4.00M | -167.40% |
Free cash flow | -505.50K | 90.02% |
Previous close
$0.65
Day range
$0.63 - $0.68
Year range
$0.51 - $1.61
Market cap
36.47M USD
Avg Volume
152.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2013
Website
Employees
32
